SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899866-19-000085
Filing Date
2019-07-24
Accepted
2019-07-24 06:46:36
Documents
16
Period of Report
2019-07-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k07242019.htm   iXBRL 8-K 37322
2 EXHIBIT 99.1 ex99107242019.htm EX-99.1 610937
8 a2016earningsreleaseimagea25.jpg GRAPHIC 12335
  Complete submission text file 0000899866-19-000085.txt   831848

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxn-20190630.xsd EX-101.SCH 4453
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alxn-20190630_cal.xml EX-101.CAL 639
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alxn-20190630_def.xml EX-101.DEF 1489
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxn-20190630_lab.xml EX-101.LAB 23061
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxn-20190630_pre.xml EX-101.PRE 12071
9 EXTRACTED XBRL INSTANCE DOCUMENT a8-k07242019_htm.xml XML 4123
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 19969175
SIC: 2834 Pharmaceutical Preparations